Enanta Pharmaceuticals 10K 2024 Annual report | ENTA Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abrocitinib, ABRYSVO, ADBRY, ADME, alerting, allergic, angioedema, anxiety, atopic, AUC, autoimmune, barzolvolimab, biologic, BIOSECURE, black, Blueprint, bona, box, briquilimab, Bruton, BTK, burning, cascade, Celldex, CIBINQO, CIndU, Clawback, cloud, composed, concept, CRSwNP, crucial, CSU, culture, debilitating, deep, degranulation, depleting, depletion, deposit, depository, dermatological, differentiated, disaggregate, disaggregated, Disaggregation, disorder, dry, dupilumab, dupixent, Dysregulation, efficiently, elevation, encryption, EoE, eosinophilic, Evommune, exempt, factor, FDIC, fide, fight, flexibility, float, footage, formally, GI, Harmonic, hearing, helper, histamine, IgE, Immunoglobulin, implicated, inactivation, Incyte, inflamed, inflammatory, innate, inoculated, inventory, IRP, irritability, irritated, IRS, itchy, JAK, Jasper, kinase, Kingsbury, KIT, Kymera, layer, lifestyle, MACE, malignancy, manifested, mast, men, modulate, Monthly, myeloid, nasal, NIST, oA, oAn, oIn, oNo, oPediatric, opposed, overactive, overproduction, pain, PBM, pharmacy, phenotype, phishing, PN, predominantly, presence, probing, procedural, pronounced, proof, propagation, prototype, prurigo, quantity, ransomware, RASP, reaction, reclassified, red, refund, relieve, remission, RINVOQ, root, RSVt, Russian, scanning, school, Senate, sensation, Septerna, shape, shutting, Silicon, simulated, size, skin, sleep, soft, stimulation, subcommittee, swelling, tabular, threat, tingling, transducer, triage, tryptase, tyrosine, uncommon, uncontrolled, unfriendly, upadacitinib, urticaria, Valley, virtual, vISO, zelicapavir

Removed: agonist, Aid, allegedly, allocable, attracted, attributable, baseline, blocked, deployed, detail, deteriorate, ESPP, exhibited, forward, FXR, hMPV, hospitalized, Integrated, intensity, Linkbase, mode, newest, nominated, pertain, reliability, Relief, remdesivir, reserve, RSVP, scheduled, travel, variant, viremic


NAME	PARENT	STATE OR COUNTRY OF INCORPORATION

Enanta Pharmaceuticals Security Corporation	Enanta Pharmaceuticals, Inc.	Massachusetts

Enanta Pharmaceuticals (ENTA) 10-K2024 FY Annual report

Content analysis